Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPAS1 | Q99814 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Haliclonadiamine SCHEMBL6264467 | 1.00 | EPAS1 (1.00) | EPAS1 | |
| SCHEMBL6899307 | 0.72 | EPAS1 (0.56) | EPAS1 | |
| SCHEMBL4623146 | 0.72 | EPAS1 (0.56) | EPAS1 | |
| SCHEMBL16878076 | 0.68 | — | — | |
| SCHEMBL16878031 | 0.66 | — | — | |
| SCHEMBL19541639 | 0.66 | EPAS1 (0.48) | EPAS1 | |
| SCHEMBL23946276 | 0.65 | — | — | |
| SCHEMBL4904117 | 0.65 | — | — | |
| SCHEMBL14828404 | 0.65 | — | — | |
| SCHEMBL9486149 | 0.65 | EPAS1 (0.47) | EPAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1776071-A2 | COATED VAGINAL DEVICES FOR VAGINAL DELIVERY OF THERAPEUTICALLY EFFECTIVE AND/ OR HEALTH-PROMOTING AGENTS | UMD, Inc. (US) | 2007-04-25 | — | — | EP | claimed |
| WO-2006017341-A2 | COATED VAGINAL DEVICES FOR VAGINAL DELIVERY OF THERAPEUTICALLY EFFECTIVE AND/ OR HEALTH-PROMOTING AGENTS | UMD, INC. (US) | 2006-02-16 | — | — | WO | claimed |
| US-20050276836-A1 | Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents | UMD, INC. | 2005-12-15 | — | — | US | claimed |
| WO-2005084157-A2 | METHODS OF TREATING DISEASE THROUGH THE ADMINISTRATION OF A MANZAMINE ANALOG OR DERIVATIVE | UNIVERSITY OF MISSISSIPPI (US) | 2005-09-15 | — | — | WO | claimed |
| US-20050085554-A1 | Methods of treating disease through the administration of a manzamine analog or derivative | MISSISSIPPI, UNIVERSITY OF, THE | 2005-04-21 | — | — | US | claimed |
| US-20100028469-A1 | Extracts of Cranberry and Methods of Using Thereof | HERBALSCIENCE GROUP, LLC (US) | 2010-02-04 | — | — | US | disclosed |
| US-20080154035-A1 | COUPLING METHOD BETWEEN INTRAMOLECULAR CARBON IN UNSATURATED HYDROCARBON COMPOUND USING ORGANO-INDIUM COMPOUND AS COUPLING AGENT | PHIL HO LEE (KR) | 2008-06-26 | — | — | US | disclosed |
| EP-1776071-A2 | COATED VAGINAL DEVICES FOR VAGINAL DELIVERY OF THERAPEUTICALLY EFFECTIVE AND/ OR HEALTH-PROMOTING AGENTS | UMD, Inc. (US) | 2007-04-25 | — | — | EP | disclosed |
| WO-2006017341-A2 | COATED VAGINAL DEVICES FOR VAGINAL DELIVERY OF THERAPEUTICALLY EFFECTIVE AND/ OR HEALTH-PROMOTING AGENTS | UMD, INC. (US) | 2006-02-16 | — | — | WO | disclosed |
| US-20050276836-A1 | Coated vaginal devices for vaginal delivery of therapeutically effective and/or health-promoting agents | UMD, INC. | 2005-12-15 | — | — | US | disclosed |
| WO-2005084157-A2 | METHODS OF TREATING DISEASE THROUGH THE ADMINISTRATION OF A MANZAMINE ANALOG OR DERIVATIVE | UNIVERSITY OF MISSISSIPPI (US) | 2005-09-15 | — | — | WO | disclosed |
| US-20050085554-A1 | Methods of treating disease through the administration of a manzamine analog or derivative | MISSISSIPPI, UNIVERSITY OF, THE | 2005-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085554-A1 | Methods of treating disease through the administration of a manzamine analog or derivative | MANBA, MAN2A1, MAN2B1 | EPAS1 4545/4885 |
| US-20080154035-A1 | COUPLING METHOD BETWEEN INTRAMOLECULAR CARBON IN UNSATURATED HYDROCARBON COMPOUND USING ORGANO-INDIUM COMPOUND AS COUPLING AGENT | AHR, INTS9, ARNT | EPAS1 3560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.